| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest. Today, you can see them free.
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Back on September 4, economic bellwether FedEx ( FDX - Analyst Report ) warned about weakness in the global economy affecting their earnings. On Tuesday, the express delivery firm reiterated those concerns after reporting results for the first quarter of its fiscal 2013.
FedEx warned of weaker-than-expected economic growth not just in the developed world, but in China too. On the conference call, CEO Fred Smith gave these ominous warnings:
"Global trade has grown faster than GDP, except for the 2000, 2001 meltdown and 2008 and 2009 for 25 years. And over the last few months, that has not been the case.... exports and trade have gone down at a faster rate than GDP has."
And on China, he said this:
"The locomotive that has driven China's growth is its export industries. And with the situation in Europe and, to a lesser degree, in North America; that is a significant issue for the Chinese economy."
The company also lowered its 2013 earnings guidance from a range of $6.90-$7.40 per share to $6.20-$6.60. That's quite a hair cut.
So what does FedEx's gloomy outlook mean for third quarter earnings season next month? Keep in mind that fellow economic bellwethers like Cummins ( CMI - Analyst Report ) issued similar warnings ahead of second quarter earnings season in July. But for the most part, Q2 earnings season held up and stocks have soared since then.
Do you think today's comments from FedEx are a warning signal for the overall stock market, or just another false alarm? Chime in below.
Read the full reports :
Analyst Report on CMI
Analyst Report on FDX